Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2022.935224
Keywords
RNA metabolism; stemness; tumorigenesis; N-6-methyladenose; reprogramming
Categories
Funding
- National Natural Science Foundation of China (NSFC) [82103245, 81972576]
- RGC-CRF Hong Kong [C4039-19GF]
- RGC-GRF Hong Kong [14107321, 14110819]
- Heath and Medical Research Fund (HMRF) [18190951]
- CUHK Direct Grant for Research [2020.006]
Ask authors/readers for more resources
N-6-Methyladenosine (m(6)A) is a common modification on eukaryote messenger RNA, playing a crucial role in posttranscriptional regulation. Recent studies have shown that perturbation of m(6)A regulators can greatly affect cell fate transitions and is associated with various diseases, including cancer.
N-6-Methyladenosine (m(6)A) is the most abundant modification on eukaryote messenger RNA and plays a key role in posttranscriptional regulation of RNA metabolism including splicing, intracellular transport, degradation, and translation. m(6)A is dynamically regulated by methyltransferases (writers), RNA-binding proteins (readers), and demethylases (erasers). Recent studies demonstrate that perturbation of m(6)A regulators remarkably influences cell fate transitions through rewiring various biological processes, such as growth, differentiation, and survival. Moreover, aberrant m(6)A modification is implicated in a variety of diseases, in particular cancer. In this review, we describe the functional linkage of m(6)A modifications to cellular reprogramming and cancer stemness properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
